AGENDA
Time
Session
18:00–18:05
Welcome and introductions (5 mins)
18:05–18:12
Tofacitinib: an alternative treatment option for JIA (7 mins)
18:12–18:22
Efficacy of tofacitinib in patients with JIA (10 mins)
18:22–18:32
Safety of tofacitinib in patients with JIA (10 mins)
18:32–18:40
Unmet needs for patients & carers with JIA (8 mins)
18:40–18:55
Q&A and discussion (15 mins)
18:55–19:00
Summary and close (5 mins)